Article Text
Statistics from Altmetric.com
To the Editor: The potential cost-effectiveness (CE) of adopting innovative procedures within a publically funded healthcare system is a recurring issue.1 Trans-catheter aortic valve insertion (TAVI) is not currently provided by the devolved National Health Service in Scotland, although a single high quality randomised controlled clinical trial (RCT) has demonstrated that TAVI is a clinically effective intervention for reducing the risk of death in older patients with severe aortic stenosis considered unfit for standard surgery.2 The recently published CE analysis of TAVI reports an incremental …
Footnotes
Linked article 302271.
Competing interests None.
Provenance and peer review Not commissioned; internally peer reviewed.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Linked Articles
- PostScript